| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $54.4M | +11.0% |
| R&D Expense | $3.2M | +12.5% |
| Operating Income | $10.3M | +9.5% |
| Pre-tax Income | $11.0M | +12.1% |
| Income Tax | $2.5M | +17.2% |
| Net Income | $8.4M | +10.6% |
| EPS (Basic) | $2.94 | +5.8% |
| EPS (Diluted) | $2.62 | -1.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.9M | +65.3% |
| Accounts Receivable | $6.7M | -2.7% |
| Inventory | $9.7M | +1.7% |
| Current Assets | $61.2M | +105.8% |
| Total Assets | $68.4M | +87.4% |
| Current Liabilities | $4.9M | -6.2% |
| Total Liabilities | $5.2M | -0.9% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.7M | +41.7% |
| Capital Expenditures | $2.6M | +34.4% |
| Investing Cash Flow | -$2.6M | -34.4% |
| Financing Cash Flow | $142K | -95.4% |
| Free Cash Flow | $8.1M | +44.2% |
| $63.2M |
| +102.1% |